163 related articles for article (PubMed ID: 10824706)
1. The effect of epitestosterone on estrogen biosynthesis in vitro.
Bicíková M; Klak J; Hill M; Stárka L
Horm Metab Res; 2000 Apr; 32(4):125-8. PubMed ID: 10824706
[TBL] [Abstract][Full Text] [Related]
2. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
Smuc T; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies of the aromatization of testosterone and epitestosterone by human placental aromatase.
Finkelstein M; Weidenfeld J; Ne'eman Y; Samuni A; Mizrachi Y; Ben-Uzilio R
Endocrinology; 1981 Mar; 108(3):943-7. PubMed ID: 7460853
[TBL] [Abstract][Full Text] [Related]
4. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of intermediates and isotopically sensitive enolization distinguish between aromatase (cytochrome P450 CYP19) from rat ovary and human placenta.
Swinney DC; Watson DM; So OY
Arch Biochem Biophys; 1993 Aug; 305(1):61-7. PubMed ID: 8342956
[TBL] [Abstract][Full Text] [Related]
6. Enzyme interactions of 2,10-ethanoandrostene-3,17-dione: aromatase and 17 beta-hydroxysteroid dehydrogenase.
Greway AT; Mentzer M; Levy MA
Biochem Int; 1990; 20(3):591-7. PubMed ID: 2161228
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acids promote the action of aromatase and 17beta-hydroxysteroid dehydrogenase type 1 on the biosynthesis of 17beta-estradiol in placental cells.
Zhu SJ; Li Y; Li H; Wang YL; Xiao ZJ; Vihko P; Piao YS
J Endocrinol; 2002 Jan; 172(1):31-43. PubMed ID: 11786372
[TBL] [Abstract][Full Text] [Related]
8. Gender differences of enzymatic activity and distribution of 17beta-hydroxysteroid dehydrogenase in human skin in vitro.
Hikima T; Maibach HI
Skin Pharmacol Physiol; 2007; 20(4):168-74. PubMed ID: 17396051
[TBL] [Abstract][Full Text] [Related]
9. Expression of functional aromatase in the epididymis: role of androgens and LH in modulation of expression and activity.
Shayu D; Rao AJ
Mol Cell Endocrinol; 2006 Apr; 249(1-2):40-50. PubMed ID: 16569475
[TBL] [Abstract][Full Text] [Related]
10. The effect of methadone and buprenorphine on human placental aromatase.
Zharikova OL; Deshmukh SV; Nanovskaya TN; Hankins GD; Ahmed MS
Biochem Pharmacol; 2006 Apr; 71(8):1255-64. PubMed ID: 16455059
[TBL] [Abstract][Full Text] [Related]
11. Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells.
Brooks JD; Thompson LU
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):461-7. PubMed ID: 15876411
[TBL] [Abstract][Full Text] [Related]
12. Relative involvement of three 17beta-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors.
Laplante Y; Rancourt C; Poirier D
Mol Cell Endocrinol; 2009 Mar; 301(1-2):146-53. PubMed ID: 18812208
[TBL] [Abstract][Full Text] [Related]
13. Human estrogenic 17beta-hydroxysteroid dehydrogenase: predominance of estrone reduction and its induction by NADPH.
Jin JZ; Lin SX
Biochem Biophys Res Commun; 1999 Jun; 259(2):489-93. PubMed ID: 10362535
[TBL] [Abstract][Full Text] [Related]
14. Influence of oleoyl-estrone treatment on circulating testosterone. Role of 17beta-hydroxysteroid dehydrogenase isoenzymes.
Romero MM; Vila R; Fernandez-Lopez JA; Esteve M; Alemany M
J Physiol Pharmacol; 2009 Mar; 60(1):181-90. PubMed ID: 19439821
[TBL] [Abstract][Full Text] [Related]
15. Estradiol formation by human osteoblasts via multiple pathways: relation with osteoblast function.
Janssen JM; Bland R; Hewison M; Coughtrie MW; Sharp S; Arts J; Pols HA; van Leeuwen JP
J Cell Biochem; 1999 Dec; 75(3):528-37. PubMed ID: 10536374
[TBL] [Abstract][Full Text] [Related]
16. Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity.
Chetrite GS; Thole HH; Philippe JC; Pasqualini JR
Anticancer Res; 2004; 24(3a):1433-8. PubMed ID: 15274306
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor specificity of the placental microsomal oxidase system responsible for the aromatization of epitestosterone (17 alpha-hydroxy-4-androsten-3-one).
Sheean LA; Meigs RA
Steroids; 1983 Feb; 41(2):225-41. PubMed ID: 6658871
[TBL] [Abstract][Full Text] [Related]
18. Estrogen formation in endometrial and cervix cancer cell lines: involvement of aromatase, steroid sulfatase and 17beta-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12).
Fournier MA; Poirier D
Mol Cell Endocrinol; 2009 Mar; 301(1-2):142-5. PubMed ID: 18817841
[TBL] [Abstract][Full Text] [Related]
19. Estrone/17beta-estradiol conversion to, and tumor necrosis factor inhibition by, estrogen metabolites in synovial cells of patients with rheumatoid arthritis and patients with osteoarthritis.
Schmidt M; Hartung R; Capellino S; Cutolo M; Pfeifer-Leeg A; Straub RH
Arthritis Rheum; 2009 Oct; 60(10):2913-22. PubMed ID: 19790073
[TBL] [Abstract][Full Text] [Related]
20. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
Laplante Y; Cadot C; Fournier MA; Poirier D
Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
